Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "indolethylamine N-methyltransferase pseudogene" (ENSG00000223419) is a pseudogene, meaning it is a non-functional segment of DNA that resembles the gene encoding indolethylamine N-methyltransferase (INMT) but lacks protein-coding potential. Pseudogenes typically arise from gene duplication or retrotransposition events and do not produce a functional protein product. Unlike the functional INMT gene, which encodes an enzyme involved in the metabolism of indolethylamines (such as tryptamine and serotonin) and is implicated in various physiological and pathological processes, the pseudogene does not participate in known biological pathways or serve as a drug target[2]. Essential context: INMT (the functional gene, not the pseudogene) is sometimes studied in the context of neurotransmitter metabolism, neuropsychiatric disorders, and cancer[1][3]. Any references to disease relevance, mechanism of action, or druggability pertain to the protein-coding INMT gene, not to this pseudogene[1][3][5]. For structured data extraction and therapeutic relevance, the focus should always be on the protein-coding gene, not its pseudogene form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Indolethylamine N-methyltransferase pseudogene.